This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Understanding the pillars of financial independence is essential for achieving financial freedom. Learn the key concepts to empower your journey.
16,734 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A nationwide recall has been issued for nearly 90,000 bottles children's ibuprofen after reports of contamination. Fa...
The latest inflation report out shows retirees still face rising essentials even as COLA gains ease. Here's what that...
A groundbreaking 2026 risk study places hail risk homes with exposure on a footing with major hurricane threats, prom...
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
Families earning around $200,000 are weighing whether shifting retirement contributions can unlock substantial colleg...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...
The SpaceX IPO could unlock a new era for private-market access. This guide breaks down why SpaceX matters, how to ge...
A Washington nonprofit filed a federal lawsuit this week to stop the blue repainting of the Lincoln Memorial Reflecti...
The administration moved to suspend the costly entry bond for foreign ticket holders from World Cup nations, easing t...
A single AI stock could outperform the rest on Nasdaq by the end of 2026. This article breaks down why that might hap...
Social Security is a cornerstone of retirement income, but when and how you claim matters. This practical guide offer...